Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8387574 | 0.82 | GABRA1 (0.48) | GABRA1GABRB2CYP2A6CYP1A2TRPA1 | |
| SCHEMBL2687017 | 0.82 | GABRA1 (0.48) | GABRA1GABRB2CYP2A6CYP1A2TRPA1 | |
| SCHEMBL1535127 | 0.78 | CA2 (0.48) | GABRA1GABRB2ATMTSHRALDH1A1 | |
| SCHEMBL7066555 | 0.78 | — | — | |
| SCHEMBL3105850 | 0.74 | MEN1 (0.37) | CYP2A6CYP1A2ATMTSHRALDH1A1 | |
| SCHEMBL3106196 | 0.74 | CES2 (0.34) | ACHECA2 | |
| SCHEMBL1927917 | 0.73 | GABRA1 (0.58) | GABRA1GABRB2CYP2A6CYP1A2TRPA1 | |
| SCHEMBL22663374 | 0.73 | GABRA1 (0.48) | GABRA1GABRB2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL16355401 | 0.73 | GABRA1 (0.47) | GABRA1GABRB2CYP2A6CYP1A2TRPA1 | |
| SCHEMBL18242325 | 0.72 | CYP2A6 (0.41) | GABRA1GABRB2CYP2A6CYP1A2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473484-B1 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | EVONIK DEGUSSA GMBH (DE) | 2015-08-19 | — | — | EP | claimed |
| EP-2886533-A1 | Use of Organophosphorus compounds based on tetraphenol (TP)-substituted structures | Evonik Degussa GmbH (DE) | 2015-06-24 | — | — | EP | claimed |
| US-9000220-B2 | Organophosphorus compounds based on tetraphenol (TP)-substituted structures | EVONIK DEGUSSA GMBH (DE) | 2015-04-07 | — | — | US | claimed |
| US-20120197025-A1 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | EVONIK OXENO GMBH (DE) | 2012-08-02 | — | — | US | claimed |
| EP-2473484-A2 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | Evonik Oxeno GmbH (DE) | 2012-07-11 | — | — | EP | claimed |
| WO-2011023756-A2 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | EVONIK OXENO GMBH (DE) | 2011-03-03 | — | — | WO | claimed |
| CN-113387055-B | Film, method for producing film, and bag | 住友化学株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-112724302-B | Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film | 住友化学株式会社 | 2023-10-31 | — | — | CN | disclosed |
| US-11643533-B2 | Film, method of producing film, and bag | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-112638997-B | Film and packaging container | 住友化学株式会社 | 2023-04-28 | — | — | CN | disclosed |
| CN-110352213-B | Film | 住友化学株式会社 | 2022-09-09 | — | — | CN | disclosed |
| US-11149102-B2 | Film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-10-19 | — | — | US | disclosed |
| US-20210284829-A1 | FILM, METHOD OF PRODUCING FILM, AND BAG | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-09-16 | — | — | US | disclosed |
| US-20010053832-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-20 | — | — | US | disclosed |
| EP-1153938-A1 | CATALYST FOR STEREOREGULAR POLYMERIZATION OF ALPHA-OLEFIN AND PROCESS FOR PRODUCING STEREOREGULAR ALPHA-OLEFIN POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-11-14 | — | — | EP | disclosed |
| CN-1314420-A | Olefine polymerization catalyst and method for preparing olefine polymer | SUMITOMO CHEMICAL CO (JP) | 2001-09-26 | — | — | CN | disclosed |
| EP-1134234-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-19 | — | — | EP | disclosed |
| EP-1081167-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-07 | — | — | EP | disclosed |
| EP-0731805-A1 | AMIDES OF ACIDS OF PHOSPHORUS FOR THE EXTRACTION OF METALS | ZENECA LIMITED (GB) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015329-A1 | AMIDES OF ACIDS OF PHOSPHORUS FOR THE EXTRACTION OF METALS | ZENECA LIMITED (GB) | 1995-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120197025-A1 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | PTMS, HPD, INPPL1 | GABRA1 4534/4885GABRB2 4583/4885CYP2A6 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.